16.3
ImmuCell Corporation
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
14.0
FY23:
11.5
FY24:
15.0
FY25:
16.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.2
FY22:
30.9
FY23:
32.3
FY24:
30.1
FY25:
25.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
44.5
FY22:
44.9
FY23:
43.8
FY24:
45.1
FY25:
42.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.53
FY22:
3.07
FY23:
4.20
FY24:
4.41
FY25:
3.98
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.35
FY22:
11.4
FY23:
14.6
FY24:
13.2
FY25:
11.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.6
FY22:
30.4
FY23:
25.0
FY24:
27.5
FY25:
27.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
44.5
FY22:
44.9
FY23:
43.8
FY24:
45.1
FY25:
42.5
All amounts in millions USD